Navigation Links
Does father know best?

A study forthcoming in the June 2006 issue of Current Anthropology sheds new light a contentious issue: How accurate are men's suspicions of whether or not they are a child's biological father? Some studies have suggested that up to 10 percent of fathers are not the biological parents of their alleged child, but little is known about how this differs across cultures and to what extent men's paternity assessments reflect actual biological paternity.

"The issue of paternity--whether a man really is the biological father of his supposed children--has long been a topic of interest to anthropologists, as well as a staple subject of idle gossip," writes Kermyt G. Anderson (University of Oklahoma and the Center for Applied Social Research). "Paternity confidence has important implications for a man's involvement with his children, since men are less likely to interact with and support children whom they do not believe to be theirs."

Anderson compared the paternity test results for men with high paternity confidence to the results for men with low paternity confidence in an effort to determine how perceptions of fatherhood correlate to fact. He found that, overall, men who were confident about their fatherhood going into the test were only wrong 1.7 percent of the time, that is, they were indeed the child's father more than 98 percent of the time. Men who were dubious about their fatherhood ?specifically men who contested paternity through paternity tests ?were more frequently not the father of the child, but only in 29.8 percent of cases. More than 70 percent of the time, men who doubted their paternity were wrong.

Anderson also organized the data geographically, breaking down nonpaternity rates in different countries according to high and low paternity confidence. Among those for who paternity confidence was relatively high, actual nonpaternity is highest in Mexico and lowest among the Kohanim lineages of Sephardic Jews.


'"/>

Source:University of Chicago Press Journals


Page: 1

Related biology news :

1. Mother birds give a nutritional leg up to chicks with unattractive fathers
2. Older fathers more likely to have autistic children
3. Egyptians, not Greeks were true fathers of medicine
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Does father know best

(Date:12/14/2009)... feature of humans. That,s until examples of tool use came ... of other mammals. Now, a report in the December 14th ... adds an octopus to the growing list of tool users. ... that the researchers call stilt walking. In it, the soft-bodied ... its eight arms rigid, and raises the whole assembly to ...
(Date:12/14/2009)... -- MODA Technology Partners, a global software company ... testing for the Pharmaceutical industry, today announced the ... generation mobile data acquisition platform. The latest release ... their regulated manufacturing processes. ,, MODA 3.0 ... Fully-Configurable Test Methods: Each test method in ...
(Date:12/13/2009)... have identified plant enzymes that may help to engineer ... use water more efficiently. The finding could help to ... , Plants take in the carbon dioxide they need ... of leaves. But for each molecule of the gas ... same openings. The pores can tighten to save water ...
Breaking Biology News(10 mins):Tool use in an invertebrate: The coconut-carrying octopus 2MODA Announces Availability of Third Generation Mobile Data Acquisition Platform 2Newly identified enzymes help plants sense elevated CO2 and could lead to water-wise crops 2Newly identified enzymes help plants sense elevated CO2 and could lead to water-wise crops 3TV Interferes With Infants Language Development 47700 1TV Interferes With Infants Language Development 47700 2Optimer Pharmaceuticals Announces Lower Recurrence Rates for Fidaxomicin Versus Vancocin 28R 29 in Subgroup Analyses from Its Phase 3 Study for the Tr 12427 1Optimer Pharmaceuticals Announces Lower Recurrence Rates for Fidaxomicin Versus Vancocin 28R 29 in Subgroup Analyses from Its Phase 3 Study for the Tr 12427 2Optimer Pharmaceuticals Announces Lower Recurrence Rates for Fidaxomicin Versus Vancocin 28R 29 in Subgroup Analyses from Its Phase 3 Study for the Tr 12427 3Optimer Pharmaceuticals Announces Lower Recurrence Rates for Fidaxomicin Versus Vancocin 28R 29 in Subgroup Analyses from Its Phase 3 Study for the Tr 12427 4Optimer Pharmaceuticals Announces Lower Recurrence Rates for Fidaxomicin Versus Vancocin 28R 29 in Subgroup Analyses from Its Phase 3 Study for the Tr 12427 5Dr Erika Says Newsweek 26apos 3Bs Attack on Oprah Ignores the Many Benefits of Her Health Care Advocacy 47696 1Dr Erika Says Newsweek 26apos 3Bs Attack on Oprah Ignores the Many Benefits of Her Health Care Advocacy 47696 2
... in a population because predators detect common forms of prey ... BMC Ecology found that birds will target salamanders that ... response to alterations in the ratio of a distinguishing trait. ... with Kim Shook and Reuben Izally to study the effects ...
... and Hosting Services Enhances Law Enforcement Information SharingWALL, ... Bulletin Board: BKYI), a leader in finger-based biometric ... a strategic partnership with Nlets. Nlets is the ... network for the exchange of law enforcement, criminal ...
... scientists report for the first time on the only known ... frequencies are too high to be heard by humans. Known ... only on the Southeast Asian island of Borneo. , ... frequency, which exceeds the upper limit of sounds detectable by ...
Other Biology News:BIO-key(R) Enters Strategic Partnership With Nlets 2BIO-key(R) Enters Strategic Partnership With Nlets 3UCLA scientists discover ultrasonic communication among frogs 2UCLA scientists discover ultrasonic communication among frogs 3UCLA scientists discover ultrasonic communication among frogs 4
(Date:12/14/2009)... JUPITER, Fla., Dec. 14 Dyadic International, ... it has extended its collaboration with The Scripps ... with Scripps to re-annotate the genome of Dyadic,s ... agreement is a continuation of the successful relationship ... 2006 when Dyadic engaged Scripps to annotate the ...
(Date:12/14/2009)... CARLOS, Calif., Dec. 14 Nektar Therapeutics ... Winger has been appointed to serve on its ... biopharmaceutical industry leader with over 35 years of ... ,, "Dennis brings to Nektar extensive industry perspective ... said Howard W. Robin, President and CEO of ...
(Date:12/11/2009)... -- Dendreon Corporation (Nasdaq: DNDN ) announced ... public offering have exercised in full their option ... stock at the public offering price of $24.75 ... increases the size of the offering to an ... Dendreon expects to receive net proceeds from the ...
(Date:12/11/2009)... Algeta ASA (OSE: ALGETA), the,cancer therapeutics company, ... the,US, the Tulane Cancer Center, New Orleans, ... clinical study of Alpharadin in men with,castration-resistant ... has metastasized to the skeleton. , ... SYMptomatic Prostate CAncer) study is a,double-blind, randomized, ...
Breaking Biology Technology:Dyadic International Extends Collaboration With The Scripps Research Institute 2Dyadic International Extends Collaboration With The Scripps Research Institute 3Dyadic International Extends Collaboration With The Scripps Research Institute 4Dyadic International Extends Collaboration With The Scripps Research Institute 5Dennis Winger Joins Nektar Therapeutics' Board of Directors 2Dennis Winger Joins Nektar Therapeutics' Board of Directors 3Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 2Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 3Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 2Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 3Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 4
... ARLINGTON, Va., March 17 The 2008 Life ... Boston Waterfront Hotel on June,3, 2008 at a ... Leading market research firm,BioInformatics, LLC ( http://www.gene2drug.com ) ... this year,s awards., The annual awards honor ...
... Inc., a developer of advanced medical devices for ... that it has enrolled its,first patient in the ... prospective,multi-centered U.S. registry study of the company,s OmniWave(TM),Endovascular ... acute deep vein thrombosis (DVT). All patients enrolled ...
... 17 Alimera Sciences,and pSivida Ltd (Nasdaq: ... that,they have amended their license and collaboration agreement ... treatment for,diabetic macular edema (DME), and other Medidur ... profits of Medidur FA from 50 to 80,percent ...
Other Biology Technology:Life Science Industry Awards to Be Announced June 3, 2008 in Boston 2Life Science Industry Awards to Be Announced June 3, 2008 in Boston 3First Patient Enrolled in SONIC I Registry of OmniSonics Medical Technologies' OmniWave(TM) Endovascular System 2Alimera Sciences, pSivida Limited Amend Medidur(TM) FA Collaboration Agreement 2Alimera Sciences, pSivida Limited Amend Medidur(TM) FA Collaboration Agreement 3Alimera Sciences, pSivida Limited Amend Medidur(TM) FA Collaboration Agreement 4
An excellent carbonyl-reactive FRET quencher paired with Trp or Tyr. Minimum Purity: 95%. Abs(max): ~350 nm; Em(max): none. Solvent System:DMSO or DMF....
EDG-6 (1)...
Complexin-1/2 (FL-134)...
... Comments: Ab-1 stains tumor cells of embryonal ... type of germ cell tumors like seminoma. Glandular ... are positive. Luminal and endocrine cells of stomach ... breast are also positive. Epitope: Carbohydrate ...
Biology Products: